1. Home
  2. VRNA vs AA Comparison

VRNA vs AA Comparison

Compare VRNA & AA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • AA
  • Stock Information
  • Founded
  • VRNA 2005
  • AA 1888
  • Country
  • VRNA United Kingdom
  • AA United States
  • Employees
  • VRNA N/A
  • AA N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • AA Aluminum
  • Sector
  • VRNA Health Care
  • AA Industrials
  • Exchange
  • VRNA Nasdaq
  • AA Nasdaq
  • Market Cap
  • VRNA 8.3B
  • AA 8.2B
  • IPO Year
  • VRNA 2017
  • AA 2016
  • Fundamental
  • Price
  • VRNA $106.27
  • AA $33.48
  • Analyst Decision
  • VRNA Buy
  • AA Buy
  • Analyst Count
  • VRNA 11
  • AA 12
  • Target Price
  • VRNA $114.10
  • AA $36.64
  • AVG Volume (30 Days)
  • VRNA 1.3M
  • AA 5.3M
  • Earning Date
  • VRNA 11-03-2025
  • AA 10-15-2025
  • Dividend Yield
  • VRNA N/A
  • AA 1.20%
  • EPS Growth
  • VRNA N/A
  • AA N/A
  • EPS
  • VRNA N/A
  • AA 3.87
  • Revenue
  • VRNA $221,673,000.00
  • AA $12,777,000,000.00
  • Revenue This Year
  • VRNA $896.59
  • AA $8.34
  • Revenue Next Year
  • VRNA $77.56
  • AA N/A
  • P/E Ratio
  • VRNA N/A
  • AA $8.64
  • Revenue Growth
  • VRNA N/A
  • AA 19.39
  • 52 Week Low
  • VRNA $27.54
  • AA $21.53
  • 52 Week High
  • VRNA $106.45
  • AA $47.77
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 68.40
  • AA 63.36
  • Support Level
  • VRNA $106.15
  • AA $30.71
  • Resistance Level
  • VRNA $106.42
  • AA $32.91
  • Average True Range (ATR)
  • VRNA 0.19
  • AA 1.10
  • MACD
  • VRNA -0.17
  • AA 0.19
  • Stochastic Oscillator
  • VRNA 76.32
  • AA 80.94

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About AA Alcoa Corporation

Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is the world's largest bauxite miner and alumina refiner by production volume, and the eighth-largest aluminum producer. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024, meaning refining assets are now predominantly wholly owned, as with smelting.

Share on Social Networks: